March 22, 2026 - 19:45

Coinbase has launched a new product offering 24/7 trading on major technology stocks for eligible non-U.S. retail customers. The platform now provides perpetual futures for synthetic exposure to high-profile companies like Tesla, Apple, and Nvidia, all of which are part of the so-called "Magnificent 7" stocks.
This move significantly expands the exchange's reach beyond the cryptocurrency market, allowing international traders to speculate on these equities around the clock with leverage of up to 10x. Perpetual futures are derivative contracts that mimic the price of an underlying asset without an expiry date, commonly used in crypto markets but now applied to traditional equities.
The launch positions Coinbase as a broader financial hub, often dubbed an "Everything Exchange," by merging traditional finance with digital asset infrastructure. The offering is specifically tailored for users outside the United States, adhering to varying international regulations while providing a new avenue for leveraged trading. Analysts see this as a strategic step to capture market share in the competitive retail trading sector by providing continuous access to popular stocks, mirroring the non-stop nature of cryptocurrency markets. The product underscores the growing convergence between traditional equities and digital asset trading platforms.
May 6, 2026 - 19:46
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate ProgressRevolution Medicines has released its financial results for the first quarter of 2026, alongside a significant update on its clinical pipeline. The company announced that its drug candidate...
May 6, 2026 - 01:18
Crypto’s ‘decentralised finance’ sector hit by investor exodus after hacksDecentralized finance, once hailed as the revolutionary future of banking and trading, is now dealing with a serious crisis of confidence. Investors are pulling funds out at a notable rate, driven...
May 5, 2026 - 23:12
Neurocrine Biosciences Reports First-Quarter 2026 Financial ResultsNeurocrine Biosciences released its financial report for the first quarter of 2026, covering the period ending March 31. The company disclosed its revenue and earnings figures for the three-month...
May 5, 2026 - 11:51
X Financial: From Revenue Acceleration To Surviving Market UncertaintyX Financial, the Chinese fintech company listed under the ticker XYF, is navigating a challenging period marked by declining revenue and a sharp increase in credit provisions. The company, which...